Metabolomics-based treatment for chronic diseases: results from a multidisciplinary clinical study.

ABSTRACT:

Background

Non-communicable diseases (NCDs), known as chronic diseases, significantly impact patients' quality of life (QoL) and increase medical expenses. The majority of risk factors are modifiable, and metabolomics has been suggested as a promising strategy for their evaluation, though real-world data are scarce. This study evaluated the QoL improvement and cost-effectiveness of a metabolomics-based treatment for NCDs, aiming to restore metabolic dysfunctions and nutritional deficiencies.

Methods

We performed a pre-post intervention analysis using clinical, metabolomics, QoL and economic data obtained from the electronic health records of 765 patients visiting a private practice. The intervention consisted of personalised treatment to restore metabolic dysfunctions and nu

SUBMITTER: Tsoukalas D 

PROVIDER: S-EPMC11773651 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature